Mechanisms of Aβ clearance and degradation by glial cells

Frontiers in Aging Neuroscience

Volumn 8, Issue JUN, 2016, Pages

  Ries, Miriam ^a   Sastre, Magdalena ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid ; Astrocytes; Microglia; Phagocytosis; Proteases

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CELL PROTEIN; CHAPERONE; CLUSTERIN; DIPEPTIDYL CARBOXYPEPTIDASE; FC RECEPTOR; FORMYLPEPTIDE RECEPTOR; LEUCINE RICH GLIOMA INACTIVATED PROTEIN 3; LIPOPROTEIN RECEPTOR RELATED PROTEIN 1; LYSOSOMAL PEPTIDASE; LYSOSOME ENZYME; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PLASMINOGEN ACTIVATOR; PROTEASOME; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG;

ASTROCYTE; AUTOPHAGY; ENDOCYTOSIS; EXTRACELLULAR SPACE; GLIA CELL; HUMAN; INTERNALIZATION; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; PROTEIN CLEARANCE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; SHORT SURVEY;

EID: 84983247298     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2016.00160     Document Type: Short Survey

References (115)

1. Abraham, C., Selkoe, D., Potter, H., Price, D., and Cork, L. (1989). a1-Antichymotrypsin is present together with the β-protein in monkey brain amyloid deposits. Neuroscience 32, 715-720. doi: 10.1016/0306-4522(89)90292-3
2. Abraham, C. R. (2001). Reactive astrocytes and a1-antichymotrypsin in Alzheimer's disease. Neurobiol. Aging 22, 931-936. doi: 10.1016/S0197-4580(01)00302-5
3. Alarcon, R., Fuenzalida, C., Santibanez, M., and von Bernhardi, R. (2005). Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J. Biol. Chem. 280, 30406-30415. doi: 10.1074/jbc.M414686200
4. Azevedo, F. A., Carvalho, L. R., Grinberg, L. T., Farfel, J. M., Ferretti, R. E., Leite, R. E., et al. (2009). Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 513, 532-541. doi: 10.1002/cne.21974
5. Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Games, D., Seubert, P., Schenk, D., et al. (2002). Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. J. Neurosci. 22, 7873-7878.
6. Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., and Landreth, G. E. (2003). A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23, 2665-2674.
7. Bard, F., Cannon, C., Barbour, R., Burke, R., Games, D., Grajeda, H., et al. (2000). Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916-919. doi: 10.1038/78682
8. Bates, K., Verdile, G., Li, Q., Ames, D., Hudson, P., Masters, C., et al. (2009). Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests. Mol. Psychiatry 14, 469-486. doi: 10.1038/mp.2008.96
9. Bernstein, H., Lendeckel, U., Bukowska, A., Ansorge, S., Ernst, T., Stauch, R., et al. (2008). Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary. J. Chem. Neuroanat. 35, 216-224. doi: 10.1016/j.jchemneu.2007.12.001
10. Birch, A. M., Katsouri, L., and Sastre, M. (2014). Modulation of inflammation in transgenic models of Alzheimer's disease. J. Neuroinflammation 11:25. doi: 10.1186/1742-2094-11-25
11. Blair, J. A., Siedlak, S. L., Wolfram, J. A., Nunomura, A., Castellani, R. J., Ferreira, S. T., et al. (2014). Accumulation of intraneuronal Amyloid-β is common in normal brain. Curr. Alzheimer Res. 11, 317-324. doi: 10.2174/1567205011666140302200902
12. Brandenburg, L., Konrad, M., Wruck, C., Koch, T., Pufe, T., and Lucius, R. (2008). Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization, and signal transduction of amyloid beta 1-42 in glial cells. Neuroscience 156, 266-276. doi: 10.1016/j.neuroscience.2008.07.042
13. Brandenburg, L., Konrad, M., Wruck, C. J., Koch, T., Lucius, R., and Pufe, T. (2010). Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells. J. Neurochem. 113, 749-760. doi: 10.1111/j.1471-4159.2010.06637.x
14. Braun, B. J., Slowik, A., Leib, S. L., Lucius, R., Varoga, D., Wruck, C. J., et al. (2011). The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis. J. Neuroinflammation 8:11. doi: 10.1186/1742-2094-8-11
15. Carare, R., Bernardes-Silva, M., Newman, T., Page, A., Nicoll, J., Perry, V., et al. (2008). Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol. Appl. Neurobiol. 34, 131-144. doi: 10.1111/j.1365-2990.2007.00926.x
16. Cascella, R., Conti, S., Tatini, F., Evangelisti, E., Scartabelli, T., Casamenti, F., et al. (2013). Extracellular chaperones prevent Aβ 42-induced toxicity in rat brains. Biochim. Biophys. Acta 1832, 1217-1226. doi: 10.1016/j.bbadis.2013.04.012
17. Cho, M., Cho, K., Kang, H., Jeon, E., Kim, H., Kwon, H., et al. (2014). Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy 10, 1761-1775. doi: 10.4161/auto.29647
18. Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., et al. (2002). CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils. Am. J. Pathol. 160, 101-112. doi: 10.1016/S0002-9440(10)64354-4
19. Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y., Karlo, J. C., Zinn, A. E., et al. (2012). ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503-1506. doi: 10.1126/science.1217697
20. Cucullo, L., Marchi, N., Marroni, M., Fazio, V., Namura, S., and Janigro, D. (2003). Blood-brain barrier damage induces release of alpha2-macroglobulin. Mol. Cell. Proteomics 2, 234-241. doi: 10.1074/mcp.M200077-MCP200
21. Deane, R., Bell, R. D., Sagare, A., and Zlokovic, B. V. (2009). Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 8, 16-30. doi: 10.2174/187152709787601867
22. Doens, D., and Fernández, P. L. (2014). Microglia receptors and their implications in the response to amyloid beta for Alzheimer's disease pathogenesis. J. Neuroinflammation 11:48. doi: 10.1186/1742-2094-11-48
23. Eckman, E. A., Reed, D. K., and Eckman, C. B. (2001). Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J. Biol. Chem. 276, 24540-24548. doi: 10.1074/jbc.M007579200
24. Eckman, E. A., Watson, M., Marlow, L., Sambamurti, K., and Eckman, C. B. (2003). Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J. Biol. Chem. 278, 2081-2084. doi: 10.1074/jbc.C200642200
25. El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., et al. (2003). CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 197, 1657-1666. doi: 10.1084/jem.20021546
26. Farfara, D., Trudler, D., Segev-Amzaleg, N., Galron, R., Stein, R., and Frenkel, D. (2011). γ-Secretase component presenilin is important for microglia β-amyloid clearance. Ann. Neurol. 69, 170-180. doi: 10.1002/ana.22191
27. Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., et al. (2003). Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U.S.A. 100, 4162-4167. doi: 10.1073/pnas.0230450100
28. Fisk, L., Nalivaeva, N. N., Boyle, J. P., Peers, C. S., and Turner, A. J. (2007). Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem. Res. 32, 1741-1748. doi: 10.1007/s11064-007-9349-2
29. Fu, H., Liu, B., Frost, J. L., Hong, S., Jin, M., Ostaszewski, B., et al. (2012). Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia. Glia 60, 993-1003. doi: 10.1002/glia.22331
30. Fukami, S., Watanabe, K., Iwata, N., Haraoka, J., Lu, B., Gerard, N. P., et al. (2002). Aβ-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Aβ pathology. Neurosci. Res. 43, 39-56. doi: 10.1016/S0168-0102(02)00015-9
31. Gopalan, S. M., Wilczynska, K. M., Konik, B. S., Bryan, L., and Kordula, T. (2006a). Astrocyte-specific expression of the alpha1-antichymotrypsin, and glial fibrillary acidic protein genes requires activator protein-1. J. Biol. Chem. 281, 1956-1963. doi: 10.1074/jbc.M510935200
32. Gopalan, S. M., Wilczynska, K. M., Konik, B. S., Bryan, L., and Kordula, T. (2006b). Nuclear factor-1-X regulates astrocyte-specific expression of the alpha1-antichymotrypsin, and glial fibrillary acidic protein genes. J. Biol. Chem. 281, 13126-13133. doi: 10.1074/jbc.M601194200
33. Gorina, R., Santalucia, T., Petegnief, V., Ejarque-Ortiz, A., Saura, J., and Planas, A. M. (2009). Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA. Glia 57, 93-107. doi: 10.1002/glia.20738
34. Gouras, G. K., Almeida, C. G., and Takahashi, R. H. (2005). Intraneuronal Aβ accumulation, and origin of plaques in Alzheimer's disease. Neurobiol. Aging 26, 1235-1244. doi: 10.1016/j.neurobiolaging.2005.05.022
35. Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., et al. (2008). The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9, 857-865. doi: 10.1038/ni.1636
36. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies variants at CLU, and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088-1093. doi: 10.1038/ng.440
37. Harris, F. M., Tesseur, I., Brecht, W. J., Xu, Q., Mullendorff, K., Chang, S., et al. (2004). Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J. Biol. Chem. 279, 3862-3868. doi: 10.1074/jbc.M309475200
38. Hickman, S. E., Allison, E. K., and El Khoury, J. (2008). Microglial dysfunction, and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28, 8354-8360. doi: 10.1523/JNEUROSCI.0616-08.2008
39. Holsinger, R., McLean, C. A., Beyreuther, K., Masters, C. L., and Evin, G. (2002). Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol. 51, 783-786. doi: 10.1002/ana.10208
40. Hong, L., Huang, H., and Jiang, Z. (2014). Relationship between amyloid-beta, and the ubiquitin-proteasome system in Alzheimer's disease. Neurol. Res. 36, 276-282. doi: 10.1179/1743132813Y.0000000288
41. Hu, J., Igarashi, A., Kamata, M., and Nakagawa, H. (2001). Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ); retards. (Aβ) aggregation, deposition, fibril formation; and inhibits cytotoxicity. J. Biol. Chem. 276, 47863-47868. doi: 10.1074/jbc.M104068200
42. Husemann, J., Loike, J. D., Anankov, R., Febbraio, M., and Silverstein, S. C. (2002). Scavenger receptors in neurobiology, and neuropathology: their role on microglia, and other cells of the nervous system. Glia 40, 195-205. doi: 10.1002/glia.10148
43. Igarashi, H., Suzuki, Y., Kwee, I. L., and Nakada, T. (2014). Water influx into cerebrospinal fluid is significantly reduced in senile plaque bearing transgenic mice, supporting beta-amyloid clearance hypothesis of Alzheimer's disease. Neurol. Res. 36, 1094-1098. doi: 10.1179/1743132814Y.0000000434
44. Iliff, J. J., and Nedergaard, M. (2013). Is there a cerebral lymphatic system? Stroke 44, S93-S95. doi: 10.1161/STROKEAHA.112.678698
45. Iribarren, P., Chen, K., Hu, J., Gong, W., Cho, E. H., Lockett, S., et al. (2005). CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2. FASEB J. 19, 2032-2034. doi: 10.1096/fj.05-4578fje
46. Iwata, H., Tomita, T., Maruyama, K., and Iwatsubo, T. (2001). Subcellular compartment, and molecular subdomain of beta-amyloid precursor protein relevant to the Abeta 42-promoting effects of Alzheimer mutant presenilin 2. J. Biol. Chem. 276, 21678-21685. doi: 10.1074/jbc.M007989200
47. Jansen, A. H., Reits, E. A., and Hol, E. M. (2014). The ubiquitin proteasome system in glia, and its role in neurodegenerative diseases. Front. Mol. Neurosci. 7:73. doi: 10.3389/fnmol.2014.00073
48. Jones, R. S., Minogue, A. M., Connor, T. J., and Lynch, M. A. (2013). Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47, and RAGE. J. Neuroimmune Pharmacol. 8, 301-311. doi: 10.1007/s11481-012-9427-3
49. Kanekiyo, T., Xu, H., and Bu, G. (2014). ApoE, and Aβ in Alzheimer's disease: accidental encounters or partners? Neuron 81, 740-754. doi: 10.1016/j.neuron.2014.01.045
50. Kimura, N., Ishii, Y., Suzaki, S., Negishi, T., Kyuwa, S., and Yoshikawa, Y. (2007). Aβ upregulates, and colocalizes with LGI3 in cultured rat astrocytes. Cell Mol. Neurobiol. 27, 335-350. doi: 10.1007/s10571-006-9127-8
51. Kleinberger, G., Yamanishi, Y., Suarez-Calvet, M., Czirr, E., Lohmann, E., Cuyvers, E., et al. (2014). TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci. Transl. Med. 6:243ra86. doi: 10.1126/scitranslmed.3009093
52. Klesney-Tait, J., Turnbull, I. R., and Colonna, M. (2006). The TREM receptor family, and signal integration. Nat. Immunol. 7:1266-1273. doi: 10.1038/ni1411
53. Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., et al. (2004). Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides. Nat. Med. 10, 719-726. doi: 10.1038/nm1058
54. Le, Y., Gong, W., Tiffany, H. L., Tumanov, A., Nedospasov, S., Shen, W., et al. (2001). Amyloid β42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21.
55. Le, Y., Murphy, P. M., and Wang, J. M. (2002). Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548. doi: 10.1016/S1471-4906(02)02316-5
56. Lee, C. D., and Landreth, G. E. (2010). The role of microglia in amyloid clearance from the AD brain. J. Neural. Transm. 117, 949-960. doi: 10.1007/s00702-010-0433-4
57. Lee, S., Seo, B., and Koh, J. (2015). Metallothionein-3 modulates the amyloid β endocytosis of astrocytes through its effects on actin polymerization. Mol. Brain. 8:84. doi: 10.1186/s13041-015-0173-3
58. Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., et al. (2003). Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40, 1087-1093. doi: 10.1016/S0896-6273(03)00787-6
59. Li, H. Q., Chen, C., Dou, Y., Wu, H. J., Liu, Y. J., Lou, H. F., et al. (2013). P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia. Mol. Cell Biol. 33, 4282-4293. doi: 10.1128/MCB.00544-13
60. Lilienbaum, A. (2013). Relationship between the proteasomal system, and autophagy. Int. J. Biochem. Mol. Biol. 4, 1-26.
61. Liu, Y., Walter, S., Stagi, M., Cherny, D., Letiembre, M., Schulz-Schaeffer, W., et al. (2005). LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 128, 1778-1789. doi: 10.1093/brain/awh531
62. Love, S. (2004). Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75, 1-4.
63. Lucin, K. M., O'Brien, C. E., Bieri, G., Czirr, E., Mosher, K. I., Abbey, R. J., et al. (2013). Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease. Neuron 79, 873-886. doi: 10.1016/j.neuron.2013.06.046
64. Mandrekar, S., Jiang, Q., Lee, C. Y., Koenigsknecht-Talboo, J., Holtzman, D. M., and Landreth, G. E. (2009). Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J. Neurosci. 29, 4252-4262. doi: 10.1523/JNEUROSCI.5572-08.2009
65. Melchor, J. P., and Strickland, S. (2005). Tissue plasminogen activator in central nervous system physiology, and pathology. Thromb. Haemost. 93, 655-660. doi: 10.1160/TH04-12-0838
66. Morris, A. W., Carare, R. O., Schreiber, S., and Hawkes, C. A. (2014). The cerebrovascular basement membrane: role in the clearance of β-amyloid, and cerebral amyloid angiopathy. Front. Aging Neurosci. 6:251. doi: 10.3389/fnagi.2014.00251
67. Mulder, S. D., Nielsen, H. M., Blankenstein, M. A., Eikelenboom, P., and Veerhuis, R. (2014). Apolipoproteins E, and J interfere with amyloid-beta uptake by primary human astrocytes, and microglia in vitro. Glia 62, 493-503. doi: 10.1002/glia.22619
68. Nagele, R. G., D'Andrea, M. R., Lee, H., Venkataraman, V., and Wang, H. (2003). Astrocytes accumulate Aβ42, and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 971, 197-209. doi: 10.1016/S0006-8993(03)02361-8
69. Naidoo, V., Naidoo, S., Mahabeer, R., and Raidoo, D. (2004). Cellular distribution of the endothelin system in the human brain. J. Chem. Neuroanat. 27, 87-98. doi: 10.1016/j.jchemneu.2003.12.002
70. Nakagomi, S., Kiryu-Seo, S., and Kiyama, H. (2000). Endothelin-converting enzymes, and endothelin receptor B messenger RNAs are expressed in different neural cell species, and these messenger RNAs are coordinately induced in neurons, and astrocytes respectively following nerve injury. Neuroscience 101, 441-449. doi: 10.1016/S0306-4522(00)00345-6
71. Nakanishi, H. (2003). Microglial functions, and proteases. Mol. Neurobiol. 27, 163-176. doi: 10.1385/MN:27:2:163
72. Nalivaeva, N. N., Beckett, C., Belyaev, N. D., and Turner, A. J. (2012). Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem. 120, 167-185. doi: 10.1111/j.1471-4159.2011.07510.x
73. Nixon, R. A. (2007). Autophagy, amyloidogenesis, and Alzheimer disease. J. Cell Sci. 120, 4081-4091. doi: 10.1242/jcs.019265
74. N'Songo, A., Kanekiyo, T., and Bu, G. (2013). LRP1 plays a major role in the amyloid-β clearance in microglia. Mol. Neurodegener. 8:33. doi: 10.1186/1750-1326-8-S1-P33
75. Okabayashi, S., and Kimura, N. (2008). Leucine-rich glioma inactivated 3 is involved in amyloid beta peptide uptake by astrocytes, and endocytosis itself. Neuroreport 19, 1175-1179. doi: 10.1097/WNR.0b013e32830a4cc4
76. Okun, E., Mattson, M. P., and Arumugam, T. V. (2010). Involvement of Fc receptors in disorders of the central nervous system. Neuromolecular Med. 12, 164-178. doi: 10.1007/s12017-009-8099-5
77. Pacheco-Quinto, J., and Eckman, E. A. (2013). Endothelin-converting enzymes degrade intracellular beta-amyloid produced within the endosomal/lysosomal pathway, and autophagosomes. J. Biol. Chem. 288, 5606-5615. doi: 10.1074/jbc.M112.422964
78. Pan, X., Zhu, Y., Lin, N., Zhang, J., Ye, Q., Huang, H., et al. (2011). Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease. Mol. Neurodegener. 6, 1-18. doi: 10.1186/1750-1326-6-45
79. Panaro, M., Acquafredda, A., Sisto, M., Lisi, S., Calvello, R., Mitolo, C., et al. (2007). Formyl peptide receptors on immune, and nonimmune cells: analysis of sequence conservation in FPR genes. Immunopharmacol. Immunotoxicol. 29, 243-269. doi: 10.1080/08923970701512544
80. Paresce, D. M., Ghosh, R. N., and Maxfield, F. R. (1996). Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17, 553-565. doi: 10.1016/S0896-6273(00)80187-7
81. Peress, N. S., Fleit, H. B., Perillo, E., Kuljis, R., and Pezzullo, C. (1993). Identification of FcγRI, II, and III on normal human brain ramified microglia, and on microglia in senile plaques in Alzheimer's disease. J. Neuroimmunol. 48, 71-79. doi: 10.1016/0165-5728(93)90060-C
82. Pomilio, C., Pavia, P., Gorojod, R. M., Vinuesa, A., Alaimo, A., Galvan, V., et al. (2016). Glial alterations from early to late stages in a model of Alzheimer's disease: evidence of autophagy involvement in Aβ internalization. Hippocampus 26, 194-210. doi: 10.1002/hipo.22503
83. Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., and Landreth, G. E. (2009). CD14, and toll-like receptors 2, and 4 are required for fibrillar Aβ-stimulated microglial activation. J. Neurosci. 29, 11982-11992. doi: 10.1523/JNEUROSCI.3158-09.2009
84. Richard, K. L., Filali, M., Prefontaine, P., and Rivest, S. (2008). Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42, and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 28, 5784-5793. doi: 10.1523/JNEUROSCI.1146-08.2008
85. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., et al. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771. doi: 10.1016/S0092-8674(94)90462-6
86. Saido, T., and Leissring, M. A. (2012). Proteolytic degradation of amyloid beta-protein. Cold Spring Harb. Perspect. Med. 2:a006379. doi: 10.1101/cshperspect.a006379
87. Sastre, M., Ritchie, C. W., and Hajji, N. (2015). Metal ions in Alzheimer's disease brain. JSM Alzheimer's Dis. Relat. Dement. 2:1014.
88. Saura, J., Petegnief, V., Wu, X., Liang, Y., and Paul, S. M. (2003). Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J. Neurochem. 85, 1455-1467. doi: 10.1046/j.1471-4159.2003.01788.x
89. Slowik, A., Merres, J., Elfgen, A., Jansen, S., Mohr, F., Wruck, C. J., et al. (2012). Involvement of formyl peptide receptors in receptor for advanced glycation end products(RAGE)-and amyloid beta 1-42-induced signal transduction in glial cells. Mol. Neurodegener. 7, 1-18. doi: 10.1186/1750-1326-7-55
90. Solito, E., and Sastre, M. (2012). Microglia function in Alzheimer's disease. Front. Pharmacol. 3:14. doi: 10.3389/fphar.2012.00014
91. Steneberg, P., Bernardo, L., Edfalk, S., Lundberg, L., Backlund, F., Ostenson, C. G., et al. (2013). The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of alpha-synuclein levels in beta-cells. Diabetes 62, 2004-2014. doi: 10.2337/db12-1045
92. Stocker, R., and Keaney, J. F. Jr. (2004). Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84, 1381-1478. doi: 10.1152/physrev.00047.2003
93. Tahara, K., Kim, H. D., Jin, J. J., Maxwell, J. A., Li, L., and Fukuchi, K. (2006). Role of toll-like receptor signalling in Abeta uptake, and clearance. Brain 129, 3006-3019. doi: 10.1093/brain/awl249
94. Tamboli, I. Y., Barth, E., Christian, L., Siepmann, M., Kumar, S., Singh, S., et al. (2010). Statins promote the degradation of extracellular amyloid (beta)-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion. J. Biol. Chem. 285, 37405-37414. doi: 10.1074/jbc.M110.149468
95. Tang, Y., and Le, W. (2016). Differential roles of M1, and M2 microglia in neurodegenerative diseases. Mol. Neurobiol. 53, 1181-1194. doi: 10.1007/s12035-014-9070-5
96. Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., et al. (2015). Clearance systems in the brain-implications for Alzheimer disease. Nat. Rev. Neurol. 11, 457-470. doi: 10.1038/nrneurol.2015.119
97. Trudler, D., Farfara, D., and Frenkel, D. (2010). Toll-like receptors expression, and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application. Mediators Inflamm. 2010:12. doi: 10.1155/2010/497987
98. Utter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., et al. (2008). Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. J. Neuropathol. Exp. Neurol. 67, 842-856. doi: 10.1097/NEN.0b013e3181836a71
99. van Noort, J. M., and Bsibsi, M. (2009). Toll-like receptors in the CNS: implications for neurodegeneration, and repair. Prog. Brain Res. 175, 139-148. doi: 10.1016/S0079-6123(09)17509-X
100. Verghese, P. B., Castellano, J. M., Garai, K., Wang, Y., Jiang, H., Shah, A., et al. (2013). ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc. Natl. Acad. Sci. U.S.A. 110, E1807-E1816. doi: 10.1073/pnas.1220484110
101. Wang, S., Wang, R., Chen, L., Bennett, D. A., Dickson, D. W., and Wang, D. (2010). Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J. Neurochem. 115, 47-57. doi: 10.1111/j.1471-4159.2010.06899.x
102. Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., et al. (2015). TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160, 1061-1071. doi: 10.1016/j.cell.2015.01.049
103. Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., et al. (2016). TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667-675. doi: 10.1084/jem.20151948
104. Wilcock, D. M., DiCarlo, G., Henderson, D., Jackson, J., Clarke, K., Ugen, K. E., et al. (2003). Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation. J. Neurosci. 23, 3745-3751.
105. Wildsmith, K. R., Holley, M., Savage, J. C., Skerrett, R., and Landreth, G. E. (2013). Evidence for impaired amyloid beta clearance in Alzheimer's disease. Alzheimers Res. Ther. 5:33. doi: 10.1186/alzrt187
106. Yamamoto, N., Tanida, M., Ono, Y., Kasahara, R., Fujii, Y., Ohora, K., et al. (2014). Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes. Biochem. Biophys. Res. Commun. 445, 214-217. doi: 10.1016/j.bbrc.2014.01.168
107. Yamauchi, K., Yamauchi, T., Mantuano, E., Murakami, K., Henry, K., Takahashi, K., et al. (2013). Low-density lipoprotein receptor related protein-1 (LRP1)-dependent cell signaling promotes neurotrophic activity in embryonic sensory neurons. PLoS ONE 8:e75497. doi: 10.1371/journal.pone.0075497
108. Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., et al. (2006). Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J. Biol. Chem. 281, 24566-24574. doi: 10.1074/jbc.M602440200
109. Yang, C., Shiao, Y., Shie, F., Guo, B., Chen, P., Cho, C., et al. (2011). Mechanism mediating oligomeric Aβ clearance by naïve primary microglia. Neurobiol. Dis. 42, 221-230. doi: 10.1016/j.nbd.2011.01.005
110. Yang, L., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X., et al. (2003). Elevated β-secretase expression, and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 3-4. doi: 10.1038/nm0103-3
111. Yin, K. J., Cirrito, J. R., Yan, P., Hu, X., Xiao, Q., Pan, X., et al. (2006). Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 26, 10939-10948. doi: 10.1523/JNEUROSCI.2085-06.2006
112. Yoon, S., and Jo, S. A. (2012). Mechanisms of amyloid-β peptide clearance: potential therapeutic targets for Alzheimer's disease. Biomol. Ther. 20, 245-255. doi: 10.4062/biomolther.2012.20.3.245
113. Zhao, X., and Yang, J. (2010). Amyloid-β peptide is a substrate of the human 20S proteasome. ACS Chem. Neurosci. 1, 655-660. doi: 10.1021/cn100067e
114. Zhao, Z., Xiang, Z., Haroutunian, V., Buxbaum, J. D., Stetka, B., and Pasinetti, G. (2007). M. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease. Neurobiol. Aging 28, 824-830. doi: 10.1016/j.neurobiolaging.2006.05.001
115. Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., et al. (1996). Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone, and in a complex with Alzheimer disease amyloid beta at the blood-brain, and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. U.S.A. 93, 4229-4234. doi: 10.1073/pnas.93.9.4229